Pyrls Analysis: $500K Raised
What is Pyrls?
Pyrls offers a platform for clinicians and trainees to access drug information, including medication summaries, pharmacotherapy reviews, and drug interaction tools.
Employees
3
Founded
2020
Revenue
$1-5M
Investors
- Y Combinator
- Coho Deeptech
ZoomInfo
Product Features & Capabilities
- Drug Summaries, Pharmacotherapy Reviews, Knowledge Check Assessments, Drug-Drug Interactions Tools, Fully-Automated Keyword Grouping, Backed By 15 Billion Keywords.
Pricing
-
Pyrls Free: Free forever, no credit card required
- 50+ free pharmacotherapy charts
- 800+ general drug summaries
- Featured "Knowledge Checks"
- Clinical calculators
- Mobile app & website access
- Browser Extension
-
Pyrls Pro: $15 per month paid yearly or $40 per month paid
How much Pyrls raised
Pre-Seed - $500,000
March 22, 2022Lead Investor: Y Combinator
Who are the founders of Pyrls
DB
Derek Borkowski
Founder
Market Focus
Pyrls primarily focuses on the healthcare industry, specifically in the area of drug information management and education for clinicians and trainees.
Business Model
Subscription-based model with paid plans for advanced features and free user access.
Competitors Overview
The main competitors of Pyrls in the drug information management and clinical education market include:
- Epocrates: A widely used mobile app that provides drug information, clinical guidelines, and tools for healthcare professionals. Notable advantages include its extensive database and integ
See something that needs updating? Suggest edits to this profile.